Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giada Mattiuzzo

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Molecular Therapy. Methods & Clinical Development|December 15, 2018
Lentiviral Vector Purification Using Genetically Encoded Biotin Mimic in Packaging CellLeila Mekkaoui, Farhaan Parekh, Ekaterini Kotsopoulou, et al.
Bio-Protocol|September 20, 2021
Optimised Method for the Production and Titration of Lentiviral Vectors Pseudotyped with the SARS-CoV-2 SpikeLeila Mekkaoui, Emma M Bentley, Mathieu Ferrari, et al.
Frontiers in Immunology|October 4, 2023
Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literatureDiego Cantoni, Craig Wilkie, Emma M Bentley, et al.
Plos Pathogens|December 22, 2016
Role of Occult and Post-acute Phase Replication in Protective Immunity Induced with a Novel Live Attenuated SIV VaccineNeil Berry, Maria Manoussaka, Claire Ham, et al.
Plos One|November 13, 2015
Development of Lentivirus-Based Reference Materials for Ebola Virus Nucleic Acid Amplification Technology-Based AssaysGiada Mattiuzzo, James Ashall, Kathryn S Doris, et al.
Scientific Reports|May 20, 2021
A super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infectionAmi Miller, Adam Leach, Jemima Thomas, et al.
NPJ Vaccines|June 30, 2023
Availability and use of Standards in vaccine developmentMichael Selorm Avumegah, Giada Mattiuzzo, Anna Särnefält, et al.
Plos One|August 20, 2011
Early potent protection against heterologous SIVsmE660 challenge following live attenuated SIV vaccination in Mauritian cynomolgus macaquesNeil Berry, Claire Ham, Edward T Mee, et al.
Plos One|August 28, 2014
Early biodistribution and persistence of a protective live attenuated SIV vaccine elicits localised innate responses in multiple lymphoid tissuesDeborah Ferguson, Giada Mattiuzzo, Claire Ham, et al.
Frontiers in Public Health|July 7, 2023
Evaluation of Monkeypox- and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infectionAlessandro Manenti, Niccolò Solfanelli, Paolo Cantaloni, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Molecular Therapy. Methods & Clinical Development|December 15, 2018
Lentiviral Vector Purification Using Genetically Encoded Biotin Mimic in Packaging CellLeila Mekkaoui, Farhaan Parekh, Ekaterini Kotsopoulou, et al.
Bio-Protocol|September 20, 2021
Optimised Method for the Production and Titration of Lentiviral Vectors Pseudotyped with the SARS-CoV-2 SpikeLeila Mekkaoui, Emma M Bentley, Mathieu Ferrari, et al.
Frontiers in Immunology|October 4, 2023
Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literatureDiego Cantoni, Craig Wilkie, Emma M Bentley, et al.
Plos Pathogens|December 22, 2016
Role of Occult and Post-acute Phase Replication in Protective Immunity Induced with a Novel Live Attenuated SIV VaccineNeil Berry, Maria Manoussaka, Claire Ham, et al.
Plos One|November 13, 2015
Development of Lentivirus-Based Reference Materials for Ebola Virus Nucleic Acid Amplification Technology-Based AssaysGiada Mattiuzzo, James Ashall, Kathryn S Doris, et al.
Scientific Reports|May 20, 2021
A super-potent tetramerized ACE2 protein displays enhanced neutralization of SARS-CoV-2 virus infectionAmi Miller, Adam Leach, Jemima Thomas, et al.
NPJ Vaccines|June 30, 2023
Availability and use of Standards in vaccine developmentMichael Selorm Avumegah, Giada Mattiuzzo, Anna Särnefält, et al.
Plos One|August 20, 2011
Early potent protection against heterologous SIVsmE660 challenge following live attenuated SIV vaccination in Mauritian cynomolgus macaquesNeil Berry, Claire Ham, Edward T Mee, et al.
Plos One|August 28, 2014
Early biodistribution and persistence of a protective live attenuated SIV vaccine elicits localised innate responses in multiple lymphoid tissuesDeborah Ferguson, Giada Mattiuzzo, Claire Ham, et al.
Frontiers in Public Health|July 7, 2023
Evaluation of Monkeypox- and Vaccinia virus-neutralizing antibodies in human serum samples after vaccination and natural infectionAlessandro Manenti, Niccolò Solfanelli, Paolo Cantaloni, et al.
Pageof 5